Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1935 1
1940 1
1962 1
1983 2
1984 1
1985 3
1986 1
1988 1
1989 2
1990 1
1991 5
1992 3
1993 2
1994 1
1995 1
1996 4
1997 12
1998 8
1999 3
2000 5
2001 10
2002 13
2003 9
2004 23
2005 21
2006 37
2007 41
2008 27
2009 53
2010 47
2011 94
2012 108
2013 133
2014 145
2015 148
2016 212
2017 215
2018 245
2019 283
2020 358
2021 436
2022 503
2023 584
2024 627
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,989 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA; DESTINY-Breast04 Trial Investigators. Modi S, et al. Among authors: luo t. N Engl J Med. 2022 Jul 7;387(1):9-20. doi: 10.1056/NEJMoa2203690. Epub 2022 Jun 5. N Engl J Med. 2022. PMID: 35665782 Free PMC article. Clinical Trial.
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
Cortés J, Kim SB, Chung WP, Im SA, Park YH, Hegg R, Kim MH, Tseng LM, Petry V, Chung CF, Iwata H, Hamilton E, Curigliano G, Xu B, Huang CS, Kim JH, Chiu JWY, Pedrini JL, Lee C, Liu Y, Cathcart J, Bako E, Verma S, Hurvitz SA; DESTINY-Breast03 Trial Investigators. Cortés J, et al. N Engl J Med. 2022 Mar 24;386(12):1143-1154. doi: 10.1056/NEJMoa2115022. N Engl J Med. 2022. PMID: 35320644 Clinical Trial.
Targeting mTOR for cancer therapy.
Hua H, Kong Q, Zhang H, Wang J, Luo T, Jiang Y. Hua H, et al. Among authors: luo t. J Hematol Oncol. 2019 Jul 5;12(1):71. doi: 10.1186/s13045-019-0754-1. J Hematol Oncol. 2019. PMID: 31277692 Free PMC article. Review.
Brain clearance is reduced during sleep and anesthesia.
Miao A, Luo T, Hsieh B, Edge CJ, Gridley M, Wong RTC, Constandinou TG, Wisden W, Franks NP. Miao A, et al. Among authors: luo t. Nat Neurosci. 2024 Jun;27(6):1046-1050. doi: 10.1038/s41593-024-01638-y. Epub 2024 May 13. Nat Neurosci. 2024. PMID: 38741022 Free PMC article.
Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report.
Zhang Y, Liu D, Zhang Z, Huang X, Cao J, Wang G, Du X, Wang Z, Yang M, Luo T, Liu S, Zhang W, Sheng Y, Li H, Zhang W, Chen H, Zhang S, Wang X, Meng W, Zong S, Shi M, Zheng J, Cui G. Zhang Y, et al. Among authors: luo t. J Neurol. 2024 Jul;271(7):4655-4659. doi: 10.1007/s00415-024-12367-4. Epub 2024 Apr 11. J Neurol. 2024. PMID: 38602546 No abstract available.
Macrophage iron dyshomeostasis promotes aging-related renal fibrosis.
Wu L, Lin H, Li S, Huang Y, Sun Y, Shu S, Luo T, Liang T, Lai W, Rao J, Hu Z, Peng H. Wu L, et al. Among authors: luo t. Aging Cell. 2024 Nov;23(11):e14275. doi: 10.1111/acel.14275. Epub 2024 Jul 17. Aging Cell. 2024. PMID: 39016438 Free PMC article.
3,989 results